1. Home
  2. LEGN vs JBTM Comparison

LEGN vs JBTM Comparison

Compare LEGN & JBTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
    SELLHOLDBUYas of 17 hours ago
  • JBTM
    SELLHOLDBUYas of 2024 years ago
  • Stock Information
  • Founded
  • LEGN 2014
  • JBTM 1994
  • Country
  • LEGN United States
  • JBTM United States
  • Employees
  • LEGN N/A
  • JBTM N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • JBTM
  • Sector
  • LEGN Health Care
  • JBTM
  • Exchange
  • LEGN Nasdaq
  • JBTM Nasdaq
  • Market Cap
  • LEGN 7.0B
  • JBTM 6.4B
  • IPO Year
  • LEGN 2020
  • JBTM N/A
  • Fundamental
  • Price
  • LEGN $33.93
  • JBTM $122.09
  • Analyst Decision
  • LEGN Strong Buy
  • JBTM Strong Buy
  • Analyst Count
  • LEGN 12
  • JBTM 1
  • Target Price
  • LEGN $79.00
  • JBTM $143.00
  • AVG Volume (30 Days)
  • LEGN 1.1M
  • JBTM 479.5K
  • Earning Date
  • LEGN 03-11-2025
  • JBTM 04-30-2025
  • Dividend Yield
  • LEGN N/A
  • JBTM 0.17%
  • EPS Growth
  • LEGN N/A
  • JBTM N/A
  • EPS
  • LEGN N/A
  • JBTM 2.65
  • Revenue
  • LEGN $627,241,000.00
  • JBTM $1,716,000,000.00
  • Revenue This Year
  • LEGN $66.76
  • JBTM $113.93
  • Revenue Next Year
  • LEGN $51.82
  • JBTM $4.58
  • P/E Ratio
  • LEGN N/A
  • JBTM $46.48
  • Revenue Growth
  • LEGN 119.97
  • JBTM 3.10
  • 52 Week Low
  • LEGN $30.17
  • JBTM $82.64
  • 52 Week High
  • LEGN $60.87
  • JBTM $139.05
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 39.62
  • JBTM N/A
  • Support Level
  • LEGN $34.00
  • JBTM N/A
  • Resistance Level
  • LEGN $36.20
  • JBTM N/A
  • Average True Range (ATR)
  • LEGN 1.39
  • JBTM 0.00
  • MACD
  • LEGN -0.33
  • JBTM 0.00
  • Stochastic Oscillator
  • LEGN 18.23
  • JBTM 0.00

Stock Price Comparison Chart: LEGN vs JBTM

LEGN
JBTM
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober20250102030405060708090100110120130140LEGN VS JBTM

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About JBTM JBT Marel Corporation

JBT Marel Corp is a technology solutions provider to segments of the food and beverage industry. It designs, produces, and services products and systems for a broad range of end markets, generating roughly one-half of annual revenue from recurring parts, services, rebuilds, and leasing operations.

Share on Social Networks:

By browsing this website, you accept our Privacy Policy & Terms of Use